Skip to main content
. 2021 Jan-Feb;153(1-2):151–158. doi: 10.4103/ijmr.IJMR_3665_20

Table II.

Details of patients excluded as day 0 RT-PCR negative (n=11)

Patient number Arm Symptoms Indication for testing NEWS Day Ct Day


0 3 7 10 0 3 7 10
5 Nasal CQN Nil Contact tracing 0 0 0 0 UD UD UD UD
8 Control Fever, sore throat ×12 days Symptomatic 1 1 0 0 UD 35.2 UD UD
11 Control Nil Contact tracing 0 0 0 0 37.3 UD 32.8 37.4
16 Nasal CQN Nil Contact tracing 0 0 0 0 UD 35.9 34 UD
19 Control Chest discomfort, fever ×10 days Symptomatic, Healthcare worker 0 0 0 1 36.2 36.6 37.2 UD
21 Nasal CQN Nil Contact tracing 0 0 0 0 35 UD UD UD
22 Nasal CQN Nil Contact tracing 0 0 0 0 40 UD UD 34.8
23 Control Nil Contact tracing 0 0 0 0 35.7 35.1 32.6 30.4
31 Nasal CQN Nil Contact tracing 0 0 0 0 37.6 35.1 UD UD
58* Nasal CQN Nil Contact tracing 0 0 0 0 UD UD 37 34.5
59 Control Nil Contact tracing 0 0 0 0 36.7 25.8 UD 34.9

*Poor compliance-did not use the drug after first dose instillation. Ct, cycle threshold; UD, undetected